Pyxis Oncology GAAP EPS of -$0.35 misses by $0.05

1 month ago 3

Pyxis Oncology press release (NASDAQ:PYXS): Q1 GAAP EPS of -$0.35 misses by $0.05.
As of March 31, 2025, Pyxis Oncology had cash and cash equivalents, including restricted cash, and short-term investments, of $106.9 million. The Company believes that its current cash, cash equivalents, and short-term investments will be sufficient to fund its operations into the second half of 2026.

Recommended For You